Lenalidomide capsule 2.5mg “Sawai” by Sawai Pharmaceutical contains Lenalidomide, indicated for the treatment of multiple myeloma, myelodysplastic syndromes, follicular lymphoma, and mantle cell lymphoma. This 2.5mg 1 capsule is identified by YJ code 4291024M2055.
Lenalidomide capsule 2.5mg “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
